surface 2 115in cd3 ucht1 bioxcell be0231 200 surface 3 139la igm mhm 88 biolegend (Bio X Cell)
94
Structured Review
Bio X Cell
surface 2 115in cd3 ucht1 bioxcell be0231 200 surface 3 139la igm mhm 88 biolegend
Surface 2 115in Cd3 Ucht1 Bioxcell Be0231 200 Surface 3 139la Igm Mhm 88 Biolegend, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surface+igm/InVivoMAb+anti-human+CD3/pmc11332012__jitc___12___8___s005-0-7-12
Average 94 stars, based on 29 article reviews
Surface 2 115in Cd3 Ucht1 Bioxcell Be0231 200 Surface 3 139la Igm Mhm 88 Biolegend, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surface+igm/InVivoMAb+anti-human+CD3/pmc11332012__jitc___12___8___s005-0-7-12
Average 94 stars, based on 29 article reviews
surface 2 115in cd3 ucht1 bioxcell be0231 200 surface 3 139la igm mhm 88 biolegend - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Cell Differentiation:Article Title: Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonist. Article Snippet: For OT-II cell differentiation, mouse splenocytes were plated at 1.5 × 106 cells per ml in flat-bottom 96-well plates and stimulated with 0.05 μg ml−1 OVA323–339 peptide (GenScript, RP10610). .. For human CD4+ T cell differentiation, CD4+ T cells were plated at 0.75 × 106 cells per ml in other:Article Title: Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas Article Snippet: Article Title: Antibody-ALK5 inhibitor conjugates and their uses Article Snippet: Examples of antibodies that bind to T cell surface molecules and believed to be internalizing include OKT6 (anti-CD1; ATCC deposit no. CRL8020), OKT11 (anti-CD2; ATCC deposit no. CRL8027); OKT3 (anti-CD3; ATCC deposit no. CRL8001); OKT4 (anti-CD4; ATCC deposit no. CRL8002); OKT8 (anti-CD8; ATCC deposit no. CRL8014); 7D4 (anti-CD25; ATCC deposit no. CRL1698); OKT9 (anti-CD71; ATCC deposit no. CRL8021); CD28.2 (anti-CD28, BD Biosciences Cat. No. 556620); Cell Culture:Article Title: Design of a potent interleukin-21 mimic for cancer immunotherapy. Article Snippet: JungHo Chun†, Birkley S. Lim†, Suyasha Roy†, Michael J. Walsh†, Gita C. Abhiraman†, Kevin Zhangxu, Tavus Atajanova, OrYam Revach, Elisa C. Clark, Peng Li, Claire A. Palin, Asheema Khanna, Samantha Tower, Rakeeb Kureshi, Megan T. Hoffman, Tatyana Sharova, Aleigha Lawless, Sonia Cohen, Genevieve M. Boland, Tina Nguyen, Frank Peprah, Julissa G. Tello, Samantha Y. Liu, Chan Johng Kim, Hojeong Shin, Alfredo QuijanoRubio‡, Kevin M. Jude, Stacey Gerben, Analisa Murray, Piper Heine, Michelle DeWitt, Umut Y. Ulge, Lauren Carter, Neil P. King, DanielAdriano Silva‡, Hao Yuan Kueh, Vandana Kalia, Surojit Sarkar, Russell W. Jenkins, K. Christopher Garcia, Warren J. Leonard*, Michael Dougan*, Stephanie K. Dougan*, David Baker* Article Title: Design of a potent interleukin-21 mimic for cancer immunotherapy Article Snippet: .. Purified human CD4 + and CD8 + T cells were activated by plate-bound anti-human CD3 (2 μg/mL; clone UCHT1 (Leu-4) (T3), BioXCell Cat# Purification:Article Title: Design of a potent interleukin-21 mimic for cancer immunotherapy Article Snippet: .. Purified human CD4 + and CD8 + T cells were activated by plate-bound anti-human CD3 (2 μg/mL; clone UCHT1 (Leu-4) (T3), BioXCell Cat# In Vitro:Article Title: Selective Immune Silencing by Targeted TGF-β Agonists Article Snippet: .. For human in vitro cultures, T cells were plated at 0.75 × 10 6 cells/mL in flat-bottom 12-well plates coated overnight with 5 μg/mL Recombinant:Article Title: Selective Immune Silencing by Targeted TGF-β Agonists Article Snippet: .. For human in vitro cultures, T cells were plated at 0.75 × 10 6 cells/mL in flat-bottom 12-well plates coated overnight with 5 μg/mL |